Cellular Biomedicine Group Total Revenue

Cellular Biomedicine Group (CBMG) currently reports a total revenue of $320K as of September 2020. That compares with $75K in the prior-year period — up 330.8% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Cellular Biomedicine Group's total revenue history and peer comparisons.

Cellular Biomedicine Group's total revenue increased from $75K to $320K — a 330.8% year-over-year increase (period ending September 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cellular Biomedicine Group's total revenue of $320K is lower than the Healthcare sector average of $110B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Cellular Biomedicine Group reported $320K in total revenue as of September 2020. That compares with $75K in the prior-year period — up 330.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $320K, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Cellular Biomedicine Group, and consider following CBMG for alerts when major investors trade the stock.